In the last week, I’ve been invited to invest in two hot deals on AngelList. Both companies are doing well because of changes caused by COVID-19. One is in telehealth. The other is in food delivery. But when I checked the valuation on these deals, I was shocked. They were expensive. Both had extremely high valuations based on their current traction.   It’s clear that these startups have promise. But I decided not…